Next Article in Journal
Tumour Microenvironment Contribution to Checkpoint Inhibitor Therapy in Classic Hodgkin Lymphoma
Previous Article in Journal
CAR-T and Bispecific Antibodies: The New Standard for Relapsed and Refractory Multiple Myeloma, or Reserved for Late-Line Salvage Therapy?
 
 
Review

Article Versions Notes

Hemato 2024, 5(2), 180-198; https://doi.org/10.3390/hemato5020015
Action Date Notes Link
article xml file uploaded 31 May 2024 10:22 CEST Original file -
article xml uploaded. 31 May 2024 10:22 CEST Update https://www.mdpi.com/2673-6357/5/2/15/xml
article pdf uploaded. 31 May 2024 10:22 CEST Version of Record https://www.mdpi.com/2673-6357/5/2/15/pdf
article html file updated 31 May 2024 10:23 CEST Original file https://www.mdpi.com/2673-6357/5/2/15/html
Back to TopTop